Knockdown of Cancer Testis Antigens Modulates Neural Stem Cell Marker Expression in Glioblastoma Tumor Stem Cells

The cancer stem cell hypothesis posits that a subpopulation of cancer stem cells is frequently responsible for a tumor’s progression and resistance to treatment. The differential cellular morphology and gene expression between cancer stem cells and the majority of the tumor is becoming a point of attack for research into the next generation of therapeutic agents that may work through an induction of differentiation rather than apoptosis. Advances in the field of high-content imaging (HCI), combined with modern shRNA technology and subpopulation analysis tools, have created an ideal screening system to detect these morphological changes in a subset of cells upon gene knockdown. The authors examined several glioblastoma stem cell isolates pre- and postdifferentiation to elucidate the phenotypic effects caused by both serum differentiation and gene knockdown. Neural markers were first characterized in these cells at varying states of differentiation using HCI and immunoblots. The authors then chose one of these isolates, in both the pre- and postdifferentiated forms, for further analysis and screened for morphological changes upon shRNA knockdown of a panel of cancer testis antigens (CTAs). CTAs are a family of proteins that are normally expressed in male germ cells as well as heterogeneously expressed in some metastatic tumors. This gene family has also been implicated in the differentiation of normal human stem cells, therefore making it an ideal candidate for modulation in tumor stem cells. Using their approach, the authors identified the differential effects of gene knockdown in both cell types leading to either changes in neural stem cell marker expression or a decreased cell density likely due to growth arrest or cell death. The resolution that HCI brings to a screen at the subpopulation level makes it an excellent tool for the analysis of phenotypic changes induced by shRNA knockdown in a variety of tumor stem cells.

[1]  Jonathan Low,et al.  Prioritizing hits from phenotypic high-content screens. , 2008, Current opinion in drug discovery & development.

[2]  H. Ditzel,et al.  Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiation. , 2008, Human reproduction.

[3]  T. Jiang,et al.  Correlation of chromosomes 1p and 19q status and expressions of O6‐methylguanine DNA methyltransferase (MGMT), p53 and Ki‐67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study , 2009, Neuropathology and applied neurobiology.

[4]  Yao-Tseng Chen,et al.  Cancer/testis antigens: an expanding family of targets for cancer immunotherapy , 2002, Immunological reviews.

[5]  L. Ricci-Vitiani,et al.  Chemotherapy resistance of glioblastoma stem cells , 2006, Cell Death and Differentiation.

[6]  B. Brodin,et al.  Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression. , 2005, Cancer research.

[7]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[8]  J. Burch,et al.  High-content imaging characterization of cell cycle therapeutics through in vitro and in vivo subpopulation analysis , 2008, Molecular Cancer Therapeutics.

[9]  B. Roth,et al.  Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group , 2002, Neuroscience.

[10]  F. Grizzi,et al.  Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma , 2007, Journal of Translational Medicine.

[11]  L. Ricci-Vitiani,et al.  Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme , 2008, Clinical Cancer Research.

[12]  Michael Peyton,et al.  Synthetic lethal screen identification of chemosensitizer loci in cancer cells , 2007, Nature.

[13]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Lloyd J. Old,et al.  Cancer/testis antigens, gametogenesis and cancer , 2005, Nature Reviews Cancer.

[15]  S. Sell,et al.  Stem cell origin of cancer and differentiation therapy. , 2004, Critical reviews in oncology/hematology.

[16]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[17]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[18]  M. Westphal,et al.  Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.

[19]  D. Olive,et al.  Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. , 2000, Cancer research.

[20]  Mike Tyers,et al.  Chemical genetics reveals a complex functional ground state of neural stem cells. , 2007, Nature chemical biology.

[21]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[22]  M. Shelanski,et al.  Intermediate filaments in nervous tissues , 1978, The Journal of cell biology.

[23]  Oliver Hofmann,et al.  Genome-wide analysis of cancer/testis gene expression , 2008, Proceedings of the National Academy of Sciences.

[24]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[25]  A. Feinberg,et al.  The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells , 2007, Journal of cellular biochemistry.

[26]  K. Khalili,et al.  Class III &bgr;-Tubulin Is Constitutively Coexpressed With Glial Fibrillary Acidic Protein and Nestin in Midgestational Human Fetal Astrocytes: Implications for Phenotypic Identity , 2008, Journal of neuropathology and experimental neurology.

[27]  O. Ogawa,et al.  Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue. , 2001, The Journal of urology.